Toluca, Mexico
Mexico City, Mexico
Vallejo, Mexico
San José, Costa Rica
Panama City, Panama
Bogotà, Colombia
Quito, Ecuador
Lima, Peru
Santiago, Chile
Buenos Aires, Argentina
Rio de Janeiro, Brazil
Vitória, Brazil
Sioux City, IL USA
Des Plaines, IA USA
Bridgewater, NJ USA
Montreal, Canada
Dublin, Ireland
London, United Kingdom
Bad Oldesloe, Germany
Munich, Germany
Oss, the Netherlands
Amsterdam, the Netherlands
Brussels, Belguim
Notre Dame de Bondeville, France
Paris, France
Baar, Switzerland
Verona, Italy
Prague, Czech Republic
Ljubjana, Slovenia
Baloži, Latvia
Warsaw, Poland
Bratislava, Slovakia
Budapest, Hungary
Belgrade, Serbia
Athens, Greece
Moscow, Russia
Kiev, Ukraine
Bucharest, Romania
Sofia, Bulgaria
Hyderabad, India
Dubai, Unite Arab Emirates
Grand Bay, Mauritius

Key

Group headquarters
Combined sales, marketing, distribution and manufacturing centres
Sales, marketing and distribution centres
Marketing centres
Branch/representative offices
Manufacturing sites

Aspen’s International business comprises operating subsidiaries in Europe CIS, Latin America, Middle East and North Africa (“MENA”), Canada as well as Mauritian-based AGI, the international commercial business and intellectual property holding company which is also a primary Group trading operation and supply chain hub. Globally branded pharmaceutical products are distributed into multiple territories as well as local brands into selected regions. The API site at Oss, supported by its satellite operation at Sioux City, supplies APIs worldwide. The Notre Dame de Bondeville site primarily services Group supply needs and the Bad Oldesloe site is also an important producer for the Group.

Kuala Lumpur, Malaysia
Quarry Bay, Hong Kong
Guangzhou, China
Tokyo, Japan
Taipei, Taiwan
Manila, the Philippines
Sydney, Australia
Melbourne, Australia
Auckland, New Zealand

Key

Group headquarters
Combined sales, marketing, distribution and manufacturing centres
Sales, marketing and distribution centres
Marketing centres
Branch/representative offices
Manufacturing sites

Australia, New Zealand, the Philippines, Malaysia, Taiwan and Japan. Efforts are underway to establish an operation in China, following Aspen’s recent acquisition of anaesthetic and thrombosis products from AstraZeneca and GSK in this country. These operations supply a diversified portfolio of branded prescription, generic, OTC, consumer and infant nutritional products into Australia and New Zealand and the majority of countries in Asia. Certain tablets, liquids and semi-solids are produced at the Group’s manufacturing site in Melbourne, while other products for customers of this business are sourced from Aspen’s global manufacturing sites and accredited third-party manufacturers.

Druban, South Africa
Cape Town, South Africa
Johannesburg, South Africa
Port Elizabeth, South Africa
East London, South Africa

Key

Group headquarters
Combined sales, marketing, distribution and manufacturing centres
Sales, marketing and distribution centres
Marketing centres
Branch/representative offices
Manufacturing sites

The South African business provides a diverse basket of branded, generic, OTC, consumer health and infant nutritional products which are supplied to pharmacies, retail pharmacy chains, hospitals, clinics, prescribing specialists, dispensing general practitioners, managed healthcare funders and retail stores across the private and public sectors in South Africa.

Accra, Ghana
Lagos, Nigeria
Kampala, Uganda
Nairobi, Kenya
Dar es Salaam, Tanzania

Key

Group headquarters
Combined sales, marketing, distribution and manufacturing centres
Sales, marketing and distribution centres
Marketing centres
Branch/representative offices
Manufacturing sites

Aspen’s presence in SSA is through its wholly owned subsidiaries, Shelys (Tanzania), Beta Healthcare International (Kenya), Beta Healthcare (Uganda) and Aspen Nigeria. Aspen also has a 65% shareholding in Kama (Ghana) and exports products from South Africa into selected territories. While it was agreed to terminate the SSA Collaboration between Aspen and GSK after the 2016 year end close, the SSA Collaboration was an important contributor to the revenue of this region for the 2016 financial year. Aspen uses its own sales representation and distribution infrastructure across the region to supply a range of high quality pharmaceutical products. Aspen has its own operations in Nigeria, Ghana, Kenya, Tanzania, and Uganda, with the rest of the region being serviced through long-standing relationships with local distributors supported by sales representatives. Aspen supplies a range of branded, generic, OTC, consumer health and infant nutritional products into SSA.